), allows to explain why KIF15 will be able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by both of those mitotic motors was arrested only whenever they were individually inhibited, lending aid on the proposal that a mix drug therapy targeting these motors may be a workable